Straumann Holding AG focuses on global dental growth. Investors watch Straumann stock in a changing healthcare market

By Straumann Holding AG news desk. Reviewed on July 7, 2026 at 10:25 a.m. ET.

Straumann (ISIN CH0012280076) is one of the leading global suppliers of dental implants and orthodontic solutions, serving dentists and clinics in many countries. The company operates in a healthcare niche that continues to benefit from aging populations, rising awareness of oral health, and patients seeking aesthetic and functional improvements.

Global position in dental implants

Straumann Holding AG has built its business around dental implants, prosthetics, and biomaterials that help clinicians replace missing teeth and stabilize dentures. The company works with a network of dental professionals, training centers, and distributors to support treatment planning and clinical outcomes in implant dentistry.

Over the years, Straumann has expanded from premium implant systems into a broader portfolio, including more cost-effective options designed to make implant treatments accessible to a wider range of patients. This strategy allows the company to participate both in high-end procedures and in volume markets where affordability is crucial.

Orthodontics and digital dentistry

Beyond implants, Straumann is active in orthodontics, including clear aligner solutions that offer an alternative to traditional braces. These products support the company’s move into aesthetic dentistry, where patients are willing to pay for more discreet, comfortable treatment options.

Straumann also invests in digital dentistry, such as computer-guided surgery, intraoral scanning, and CAD/CAM-based workflows that connect clinics and labs. Digital tools help clinicians design restorations more precisely and streamline the logistics from treatment planning to the final prosthesis, which can improve efficiency for dental practices.

Representative Straumann product

One representative Straumann offering is its premium dental implant system, which combines an implant placed into the jawbone with prosthetic components and a crown or bridge. The system is designed to integrate with bone tissue, providing stable support for chewing and speaking, while also restoring the appearance of natural teeth. Straumann’s implant lines typically include different diameters and lengths to adapt to various clinical situations, from single-tooth replacement to multiple missing teeth.

Straumann stock and market context

Straumann stock trades on its home exchange in Switzerland, reflecting investor expectations about long-term demand for dental care and orthodontic treatments. For investors, key themes include the company’s ability to sustain growth in implants and clear aligners, manage pricing across premium and value segments, and continue investing in digital solutions that support clinicians and labs.

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.